CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$235.60
5.57 (2.42%)
▲
5d:
+2.73%
30d:
-1.4%
90d:
+20.67%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Smart Money Accumulation
None View Scanner →
Strength: 5.2/10
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CAH shows positive signals but monitor for confirmation. Market pricing in 1.3% growth. Moderate conviction.
💡 BUY OPPORTUNITY: CAH shows positive signals but monitor for confirmation. Market pricing in 1.3% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$331.67
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$205.94
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $235.60, which is considered slightly high relative to its 30-day fair value range of $226.95 to $237.05. The stock's valuation (Forward PE: 19.5) is in line with its historical norms (18.8). At these levels, the market is pricing in 1.3% annual earnings growth.
Technical Outlook: Technically, CAH is in a uptrend. The price is approaching resistance at $235.72. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CAH is in a uptrend. The price is approaching resistance at $235.72. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$226.95 -
$237.05
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($252.40)
- BULLISH: Expecting earnings turnaround to 1.3% growth with 11.0% revenue growth
Trading Range Analysis
30-Day Trading Range
$226.95 -
$237.05
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$220.37
Resistance Level
$235.72
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.54
Wall Street Target
$252.40
(+7.1%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-19.5%
Profit Margin
0.6%
Valuation Premium vs History
+1.3% premium
PE vs Historical
19.5 vs 18.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$238.66
(+1%)
2-Year Target
$241.77
(+3%)
3-Year Target
$244.91
(+4%)
3-Yr Target (if PE normalizes)
(PE: 20→19)
PE COMPRESSION
$235.58
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 11.9%)
$349.79
(+49%)
Base:
(SPY PE: 19.5, Growth: 11.9%)
$329.78
(+40%)
Bear:
(PE: 16.6, Growth: 11.9%)
$280.31
(+19%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 35.07 | Current EPS (TTM): $6.56
Bull Case
$464.97
(+97%)
Analyst growth 83.8%, PE expands to 38.6
Base Case
$422.70
(+79%)
Market implied 83.8%, PE stable at 35.1
Bear Case
$156.42
(-34%)
Severe decline -20.0%, PE contracts to 29.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 04, 2026 4:38 AM ET
Data refreshes hourly during market hours. Next update: 5:38 AM
Data refreshes hourly during market hours. Next update: 5:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$945 | 54 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$357 | 58 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$89 | 52 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
